These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 16194267)
1. Effectiveness of herbal medicine (Rokumigan and Hachimijiogan) for fatigue or loss of energy in patients with partial remitted major depressive disorder. Yamada K; Yagi G; Kanba S Psychiatry Clin Neurosci; 2005 Oct; 59(5):610-2. PubMed ID: 16194267 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of kamishoyosan for premenstrual dysphoric disorder: open-labeled pilot study. Yamada K; Kanba S Psychiatry Clin Neurosci; 2007 Jun; 61(3):323-5. PubMed ID: 17472603 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074 [TBL] [Abstract][Full Text] [Related]
4. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. Zhang ZJ; Kang WH; Li Q; Tan QR J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995 [TBL] [Abstract][Full Text] [Related]
5. Diagnosing major depressive disorder IV: relationship between number of symptoms and the diagnosis of disorder. Zimmerman M; McGlinchey JB; Young D; Chelminski I J Nerv Ment Dis; 2006 Jun; 194(6):450-3. PubMed ID: 16772864 [TBL] [Abstract][Full Text] [Related]
6. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Stahl SM; Zhang L; Damatarca C; Grady M J Clin Psychiatry; 2003; 64 Suppl 14():6-17. PubMed ID: 14658930 [TBL] [Abstract][Full Text] [Related]
7. Correlates of residual fatigue in patients with major depressive disorder: The role of psychotropic medication. Chung KF; Yu YM; Yeung WF J Affect Disord; 2015 Nov; 186():192-7. PubMed ID: 26247911 [TBL] [Abstract][Full Text] [Related]
8. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701 [TBL] [Abstract][Full Text] [Related]
9. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016 [TBL] [Abstract][Full Text] [Related]
10. An open-label, flexible-dose study of memantine in major depressive disorder. Ferguson JM; Shingleton RN Clin Neuropharmacol; 2007; 30(3):136-44. PubMed ID: 17545748 [TBL] [Abstract][Full Text] [Related]
11. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission. Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S; J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184 [TBL] [Abstract][Full Text] [Related]
12. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961 [TBL] [Abstract][Full Text] [Related]
13. Implicit and explicit procedural learning in patients recently remitted from severe major depression. Pedersen A; Küppers K; Behnken A; Kroker K; Schöning S; Baune BT; Rist F; Arolt V; Suslow T Psychiatry Res; 2009 Aug; 169(1):1-6. PubMed ID: 19595464 [TBL] [Abstract][Full Text] [Related]
14. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder. Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749 [TBL] [Abstract][Full Text] [Related]
15. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder. Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869 [TBL] [Abstract][Full Text] [Related]
16. A prediction rule for diagnosing hypomania. Benazzi F Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):317-22. PubMed ID: 19141309 [TBL] [Abstract][Full Text] [Related]
17. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774 [TBL] [Abstract][Full Text] [Related]
18. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS. Maes M; Mihaylova I; Kubera M; Leunis JC Neuro Endocrinol Lett; 2008 Jun; 29(3):313-9. PubMed ID: 18580855 [TBL] [Abstract][Full Text] [Related]
19. Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode. Tafalla M; Sanchez-Moreno J; Diez T; Vieta E J Affect Disord; 2009 Apr; 114(1-3):299-304. PubMed ID: 18701169 [TBL] [Abstract][Full Text] [Related]
20. Does the Aging Males' Symptoms scale assess major depressive disorder?: A pilot study. Yoshida NM; Kumano H; Kuboki T Maturitas; 2006 Jan; 53(2):171-5. PubMed ID: 16368470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]